0001415889-24-030096.txt : 20241223 0001415889-24-030096.hdr.sgml : 20241223 20241223173613 ACCESSION NUMBER: 0001415889-24-030096 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241219 FILED AS OF DATE: 20241223 DATE AS OF CHANGE: 20241223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zhao Baiteng CENTRAL INDEX KEY: 0002049287 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38560 FILM NUMBER: 241575089 MAIL ADDRESS: STREET 1: C/O AADI BIOSCIENCE, INC. STREET 2: 17383 SUNSET AVENUE, SUITE A250 CITY: PACIFIC PALISADES STATE: CA ZIP: 90272 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aadi Bioscience, Inc. CENTRAL INDEX KEY: 0001422142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 611547850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 17383 SUNSET AVENUE STREET 2: SUITE A250 CITY: PACIFIC PALISADES STATE: CA ZIP: 90272 BUSINESS PHONE: 424-473-8055 MAIL ADDRESS: STREET 1: 17383 SUNSET AVENUE STREET 2: SUITE A250 CITY: PACIFIC PALISADES STATE: CA ZIP: 90272 FORMER COMPANY: FORMER CONFORMED NAME: Aerpio Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20170316 FORMER COMPANY: FORMER CONFORMED NAME: ZETA ACQUISITION CORP II DATE OF NAME CHANGE: 20071227 4 1 form4-12232024_101210.xml X0508 4 2024-12-19 0001422142 Aadi Bioscience, Inc. AADI 0002049287 Zhao Baiteng 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 true false false false 0 Stock Option (right to buy) 2.32 2024-12-19 4 A 0 61192 0 A 2034-12-19 Common Stock 61192 61192 D Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one-thirty-sixth (1/36th) of the shares subject to the option shall vest monthly following the Date of Grant on the same day of the month as the Date of Grant (and if there is no corresponding day, the last day of the month), such that the option will be fully vested and exercisable three (3) years from the Date of Grant. "Date of Grant" shall mean December 19, 2024. /s/ Stephen Rodin, as Attorney-in-Fact 2024-12-23